Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCN5,CCN family member 5,Inverse variance weighted,12,1.07 [0.87-1.31],0.523327846675753
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,40,1.10 [0.92-1.31],0.301213178552723
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,14,0.93 [0.80-1.08],0.329167569481401
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MDK,Midkine,Inverse variance weighted,19,0.81 [0.64-1.03],0.0850747787428053
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NECTIN2,Nectin-2,Inverse variance weighted,8,1.04 [0.84-1.30],0.702587542312991
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,1.01 [0.88-1.15],0.90811935980337
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.79 [0.63-1.00],0.0543096755857644
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,0.94 [0.78-1.12],0.471671239216721
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.15 [0.72-1.86],0.559422736037099
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,0.90 [0.75-1.07],0.235154755929658
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CALB1,Calbindin,Inverse variance weighted,11,1.02 [0.74-1.40],0.926994876317429
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,1.10 [0.79-1.52],0.57745680230189
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,19,0.96 [0.75-1.23],0.74791630808693
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.72 [0.57-0.91],0.0066081222366742
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,1.04 [0.96-1.11],0.340025808761257
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.92 [0.64-1.31],0.636087758072678
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD27,CD27 antigen,Inverse variance weighted,18,0.98 [0.83-1.15],0.809402204432154
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NECTIN4,Nectin-4,Inverse variance weighted,12,0.93 [0.76-1.14],0.495708326187286
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.01 [0.77-1.31],0.966048659934865
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.95 [0.66-1.36],0.760059126722384
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,30,1.10 [0.93-1.29],0.268465019135862
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,32,0.98 [0.88-1.09],0.694068677532617
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,0.95 [0.68-1.31],0.74969545555791
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.00 [0.85-1.18],0.982334438673587
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.93 [0.75-1.16],0.526020980032948
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,1.09 [0.95-1.26],0.20006430440703
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.90 [0.81-1.01],0.0718780824646729
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.02 [0.89-1.17],0.785510564347531
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.07 [0.92-1.25],0.347422366280564
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,UMOD,Uromodulin,Inverse variance weighted,62,0.98 [0.90-1.05],0.526694677393768
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,14,1.22 [1.02-1.45],0.0264414732454508
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PGF,Placenta growth factor,Inverse variance weighted,8,0.70 [0.45-1.09],0.115303452108063
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD302,CD302 antigen,Inverse variance weighted,17,0.93 [0.77-1.14],0.49721531346306
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,11,1.26 [0.98-1.61],0.0671179973195583
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.99 [0.87-1.14],0.934570070952356
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,8,0.93 [0.76-1.13],0.473072327149726
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CBLN4,Cerebellin-4,Inverse variance weighted,17,0.89 [0.75-1.06],0.198167576885594
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.93 [0.79-1.09],0.377642610406867
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MFGE8,Lactadherin,Inverse variance weighted,26,1.02 [0.88-1.19],0.756782806985714
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.73 [0.28-1.85],0.501967592487767
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.02 [0.75-1.39],0.900124871384067
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,1.18 [0.99-1.42],0.0680265461375818
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LGALS3,Galectin-3,Inverse variance weighted,42,0.98 [0.88-1.09],0.669063698758979
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,23,0.97 [0.86-1.09],0.584020925578368
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.92 [0.77-1.10],0.370601952214652
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BRK1,Protein BRICK1,Inverse variance weighted,10,0.76 [0.56-1.05],0.093520660121661
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.55 [0.61-3.96],0.360142541988201
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,15,0.96 [0.79-1.17],0.676683796409212
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MMP3,Stromelysin-1,Inverse variance weighted,35,1.11 [0.96-1.28],0.173287561024546
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.94 [0.57-1.57],0.822102158453481
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.14 [0.96-1.36],0.136419223258946
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,INHBB,Inhibin beta B chain,Inverse variance weighted,16,0.99 [0.74-1.31],0.929801353513633
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,OCLN,Occludin,Inverse variance weighted,3,1.03 [0.57-1.87],0.909644755805154
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL4,C-C motif chemokine 4,Inverse variance weighted,38,0.99 [0.89-1.10],0.854033364464493
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.95 [0.73-1.23],0.687657149511673
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,THBD,Thrombomodulin,Inverse variance weighted,16,1.16 [0.97-1.39],0.10939367939928
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.93 [0.81-1.06],0.263223222310488
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CFC1,Cryptic protein,Inverse variance weighted,11,0.99 [0.69-1.41],0.938516571715994
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,1.09 [0.82-1.45],0.570241120961757
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.14 [0.52-2.47],0.748642127231086
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,C19orf12,Protein C19orf12,Inverse variance weighted,4,1.40 [0.80-2.45],0.233432975346677
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PCDH17,Protocadherin-17,Inverse variance weighted,47,1.02 [0.93-1.12],0.731110064398709
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,0.84 [0.65-1.09],0.193189919369303
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,28,1.12 [0.97-1.29],0.108351925245945
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ANG,Angiogenin,Inverse variance weighted,25,0.96 [0.85-1.08],0.469760339018428
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.97 [0.90-1.04],0.352074487961286
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,0.74 [0.60-0.92],0.0063859286517221
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.04 [0.95-1.13],0.41291037057756
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.89-1.11],0.91012113643903
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BSG,Basigin,Inverse variance weighted,8,0.93 [0.65-1.33],0.689662684204942
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.95 [0.86-1.06],0.357815733963103
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.08 [0.93-1.25],0.307611518561245
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,45,1.01 [0.90-1.14],0.835738135342207
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LGALS4,Galectin-4,Inverse variance weighted,19,1.09 [0.95-1.26],0.223112910565386
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,6,0.86 [0.60-1.25],0.44210376687384
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DDT,D-dopachrome decarboxylase,Inverse variance weighted,3,0.91 [0.65-1.26],0.560353045888117
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.17 [0.92-1.49],0.194834214386332
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,1.07 [0.86-1.33],0.566255391369405
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.24 [0.97-1.59],0.0809665172077232
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SERPINB8,Serpin B8,Inverse variance weighted,29,0.97 [0.90-1.04],0.364558297960379
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,27,1.06 [0.92-1.23],0.396148284331575
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.90 [0.81-1.00],0.0414907444139672
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.02 [0.92-1.13],0.651910788160907
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LGALS1,Galectin-1,Inverse variance weighted,7,1.05 [0.88-1.26],0.58246517631387
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PVR,Poliovirus receptor,Inverse variance weighted,32,0.94 [0.87-1.02],0.125121601727548
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,KLK11,Kallikrein-11,Inverse variance weighted,19,1.10 [0.98-1.24],0.0910938559205672
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,34,1.02 [0.87-1.20],0.807423570119271
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.07 [0.92-1.25],0.396897338341535
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SELE,E-selectin,Inverse variance weighted,24,1.04 [0.93-1.15],0.531662541549318
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,49,1.03 [0.94-1.13],0.525955793124765
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.94 [0.83-1.08],0.393766074360363
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.08 [0.90-1.29],0.407801209606651
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,19,1.08 [0.86-1.34],0.516273224176543
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PALM2,Paralemmin-2,Inverse variance weighted,9,0.80 [0.63-1.01],0.0651816833422177
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,13,1.00 [0.86-1.17],0.97052745840607
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AGRN,Agrin,Inverse variance weighted,31,0.99 [0.84-1.16],0.886852235631985
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.86-1.16],0.967222783080354
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCLY,Selenocysteine lyase,Inverse variance weighted,7,1.51 [1.05-2.18],0.0247531743869812
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.06 [0.88-1.26],0.556918264932638
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD276,CD276 antigen,Inverse variance weighted,47,1.13 [1.03-1.23],0.0082024633359886
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.06 [0.47-2.37],0.895234571888706
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.91 [0.62-1.34],0.632752317884633
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,4,0.94 [0.67-1.31],0.707082840047557
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.10 [0.99-1.23],0.0904474585043116
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,1.00 [0.11-8.70],0.996863554789906
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.32 [0.31-5.68],0.705177411710252
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.09 [0.91-1.31],0.349003416448429
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LEP,Leptin,Inverse variance weighted,4,0.84 [0.36-1.94],0.677513900322923
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SEPTIN8,Septin-8,Inverse variance weighted,6,0.81 [0.55-1.20],0.301351707910653
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.33 [1.00-1.77],0.0529001804792493
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GUCA2A,Guanylin,Inverse variance weighted,16,0.75 [0.57-0.98],0.0378981772316599
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CFI,Complement factor I,Inverse variance weighted,8,0.81 [0.63-1.04],0.101692945043141
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,0.67 [0.44-1.01],0.0541400099242593
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,1.04 [0.68-1.58],0.854981249671367
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.00 [0.87-1.15],0.979052594318639
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MMP8,Neutrophil collagenase,Inverse variance weighted,25,0.98 [0.86-1.12],0.805019826842093
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,0.90 [0.62-1.31],0.581738576234853
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ITGA11,Integrin alpha-11,Inverse variance weighted,16,0.94 [0.79-1.12],0.486980422755424
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.08 [0.94-1.25],0.279509412714924
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.87 [1.19-2.91],0.0061903686597632
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,0.95 [0.79-1.14],0.56820163083464
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,45,0.95 [0.88-1.04],0.254907713483243
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.28 [0.80-2.05],0.30755645944921
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.94 [0.75-1.18],0.591904596827792
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.92 [0.74-1.14],0.432166704300164
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.49 [0.58-3.88],0.409382910430795
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,0.99 [0.91-1.07],0.798383555363658
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,OSM,Oncostatin-M,Inverse variance weighted,7,1.05 [0.70-1.59],0.802645317520536
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.93 [0.76-1.15],0.502084520450872
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PRSS8,Prostasin,Inverse variance weighted,19,0.85 [0.67-1.08],0.182922008721422
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NFASC,Neurofascin,Inverse variance weighted,19,0.96 [0.83-1.10],0.550386516340012
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,0.97 [0.77-1.22],0.817685567329313
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.03 [0.92-1.16],0.556607482641719
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHGA,Chromogranin-A,Inverse variance weighted,8,0.82 [0.64-1.06],0.130719731597486
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CTSL,Cathepsin L1,Inverse variance weighted,29,0.98 [0.81-1.20],0.865767218661538
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.99 [0.72-1.36],0.959831221458586
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.46 [0.77-2.79],0.24856058467583
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ELN,Elastin,Inverse variance weighted,12,0.88 [0.56-1.39],0.580733392059762
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,31,1.00 [0.83-1.21],0.98163439115302
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.46 [0.15-1.40],0.172748368645092
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL19,Interleukin-19,Inverse variance weighted,21,1.06 [0.94-1.20],0.344463255386234
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,1.20 [0.94-1.54],0.144496946522269
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.11 [0.91-1.35],0.307231779989918
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,0.94 [0.85-1.05],0.269056442946856
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,2.10 [0.79-5.61],0.137162137791242
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,0.96 [0.88-1.04],0.326155095500901
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHGB,Secretogranin-1,Inverse variance weighted,33,1.14 [1.04-1.26],0.0064436840334732
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.91-1.12],0.868877546670517
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LAYN,Layilin,Inverse variance weighted,23,1.07 [0.91-1.25],0.431895467385575
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,1.06 [0.97-1.15],0.228798496056396
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.17 [0.88-1.56],0.291808672169943
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.76 [0.27-2.14],0.598102839307063
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.17 [0.57-2.40],0.670963054108445
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.30 [0.81-2.10],0.274158977642579
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NPL,N-acetylneuraminate lyase,Inverse variance weighted,16,0.94 [0.76-1.16],0.577230100641267
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.36 [0.51-3.64],0.544827333597371
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.92 [0.65-1.31],0.643021150007104
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,22,0.94 [0.81-1.09],0.387175710744502
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,4,1.25 [0.87-1.79],0.231894784616297
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.15 [1.00-1.32],0.0435843661055916
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RSPO3,R-spondin-3,Inverse variance weighted,11,0.99 [0.73-1.35],0.946393159620264
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.20 [0.85-1.69],0.305250140384952
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MUC13,Mucin-13,Inverse variance weighted,13,1.17 [0.90-1.51],0.23977262426079
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.89 [0.80-0.99],0.038743288173355
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,30,1.03 [0.93-1.15],0.542456401442475
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,APOC1,Apolipoprotein C-I,Inverse variance weighted,18,1.26 [0.97-1.64],0.0846297630495192
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,1.00 [0.85-1.16],0.962005537357337
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.11 [0.99-1.26],0.076099144307634
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.04 [0.64-1.68],0.873463610446908
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NRP1,Neuropilin-1,Inverse variance weighted,26,1.03 [0.89-1.19],0.728084227454416
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.04 [0.79-1.38],0.766125120914647
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.88 [0.63-1.24],0.470717577509023
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.17 [0.78-1.76],0.439630917533917
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.01 [0.72-1.41],0.971200023643087
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.88-1.12],0.906422421928512
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.05 [0.75-1.47],0.768340005168865
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.08 [0.94-1.23],0.273715991594153
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,0.97 [0.84-1.11],0.630510645377265
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.00 [0.84-1.19],0.998065069171115
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL22,Interleukin-22,Inverse variance weighted,5,0.57 [0.30-1.08],0.0849061743255032
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.06 [0.90-1.24],0.466962702255114
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,27,1.05 [0.90-1.22],0.54798904381043
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,1.06 [0.88-1.28],0.51304043762994
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL10,Interleukin-10,Inverse variance weighted,5,0.94 [0.74-1.19],0.590635476972662
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.04 [0.90-1.22],0.57646521606204
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FCN1,Ficolin-1,Inverse variance weighted,50,1.12 [0.97-1.29],0.123435129715815
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.87 [0.60-1.27],0.476790814866106
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.86 [0.66-1.11],0.242519830264439
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,XCL1,Lymphotactin,Inverse variance weighted,47,0.97 [0.88-1.05],0.435766969075556
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COCH,Cochlin,Inverse variance weighted,37,1.00 [0.90-1.11],0.962224814492372
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NRP2,Neuropilin-2,Inverse variance weighted,26,1.15 [0.96-1.38],0.133149038041267
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CDH1,Cadherin-1,Inverse variance weighted,17,0.92 [0.77-1.11],0.391697461497977
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD46,Membrane cofactor protein,Inverse variance weighted,3,0.87 [0.53-1.44],0.589988642830234
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,1.13 [0.93-1.37],0.216448317757899
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.02 [0.74-1.40],0.902977917000484
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.26 [0.91-1.75],0.157853947791198
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.86 [0.56-1.32],0.487037831648851
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.87 [0.42-1.82],0.719013077683021
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.01 [0.70-1.47],0.95078122824753
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,55,1.04 [0.98-1.11],0.226692686203664
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,1.00 [0.20-4.86],0.996977638185905
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,34,0.94 [0.85-1.03],0.191647285876756
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,0.97 [0.92-1.03],0.320028835215186
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.81 [1.09-3.01],0.0217107871346406
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.00 [0.78-1.27],0.998707415046257
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.04 [0.48-2.27],0.913127649323388
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,0.87 [0.65-1.17],0.363490557080807
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,0.93 [0.82-1.05],0.254525798733318
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL17C,Interleukin-17C,Inverse variance weighted,8,0.67 [0.47-0.96],0.0275439599647415
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CTSS,Cathepsin S,Inverse variance weighted,30,0.89 [0.78-1.03],0.116836175567285
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CDH15,Cadherin-15,Inverse variance weighted,22,0.97 [0.83-1.14],0.716298705048504
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,11,1.11 [0.84-1.46],0.474799209666676
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD83,CD83 antigen,Inverse variance weighted,19,0.94 [0.75-1.16],0.541286778780881
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.31 [0.89-1.91],0.168774696375325
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.10 [0.87-1.40],0.422707302479201
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,1.04 [0.87-1.25],0.642666034350536
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCN3,CCN family member 3,Inverse variance weighted,20,0.90 [0.76-1.07],0.242518394220239
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,THBS2,Thrombospondin-2,Inverse variance weighted,33,1.02 [0.88-1.19],0.74847784249935
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,0.70 [0.37-1.32],0.270197009165705
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.08 [0.95-1.22],0.255796211777698
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.76 [0.63-0.93],0.0063952013029365
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.24 [0.73-2.10],0.422872704468672
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.74 [0.43-1.28],0.280280024503175
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.06 [0.95-1.20],0.298293713488028
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,KLK4,Kallikrein-4,Inverse variance weighted,20,1.00 [0.88-1.14],0.946667706443967
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,0.86 [0.77-0.95],0.0040406514475249
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,1.02 [0.85-1.23],0.810990526901453
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,1.01 [0.88-1.17],0.88570334048333
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FOLR2,Folate receptor beta,Inverse variance weighted,16,1.00 [0.78-1.28],0.986816050576043
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.93 [0.71-1.22],0.597628635903599
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.81 [0.63-1.05],0.113570747817211
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MB,Myoglobin,Inverse variance weighted,10,0.89 [0.61-1.31],0.56524440687391
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PRSS2,Trypsin-2,Inverse variance weighted,22,0.91 [0.75-1.10],0.3232645806507
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TCOF1,Treacle protein,Inverse variance weighted,2,0.73 [0.30-1.78],0.491016217815759
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,12,1.03 [0.93-1.13],0.604572040707844
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.70 [0.41-1.20],0.190690201225185
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.61 [0.95-2.74],0.0762084124523682
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.01 [0.95-1.08],0.659001860978101
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CFD,Complement factor D,Inverse variance weighted,12,0.89 [0.73-1.07],0.210481002067369
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,1.10 [0.78-1.56],0.575076452808627
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.07 [0.99-1.15],0.08551180500161
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ITGA5,Integrin alpha-5,Inverse variance weighted,19,1.05 [0.83-1.34],0.662986242756502
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPP1,Osteopontin,Inverse variance weighted,19,1.15 [0.87-1.51],0.317896630821891
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,8,1.10 [0.78-1.56],0.578154982731821
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RSPO1,R-spondin-1,Inverse variance weighted,14,1.06 [0.86-1.30],0.601627977334612
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.28 [1.00-1.63],0.0485343564494432
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,0.99 [0.88-1.12],0.907499443969893
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SHISA5,Protein shisa-5,Inverse variance weighted,16,1.03 [0.72-1.46],0.877430674062696
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.22 [0.87-1.71],0.239886795905729
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.80 [0.53-1.20],0.278568918132723
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,1.09 [0.93-1.29],0.280146628997214
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SNCG,Gamma-synuclein,Inverse variance weighted,49,0.92 [0.84-1.01],0.0645487227118389
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.14 [0.85-1.53],0.388982838098772
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,28,1.00 [0.87-1.16],0.966569712767404
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPON1,Spondin-1,Inverse variance weighted,25,0.99 [0.86-1.15],0.938291860762126
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.31 [0.97-1.77],0.0780879233391837
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.93 [0.79-1.09],0.344303077146656
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.98 [0.81-1.19],0.854836088219533
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.05 [0.93-1.19],0.446307658956189
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.06 [0.82-1.38],0.657855000930221
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTH,Parathyroid hormone,Inverse variance weighted,11,0.75 [0.55-1.02],0.0709767583239399
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DPT,Dermatopontin,Inverse variance weighted,26,1.03 [0.86-1.22],0.775982356068727
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Inverse variance weighted,2,1.37 [0.59-3.18],0.46739143054309
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GAST,Gastrin,Inverse variance weighted,9,0.88 [0.60-1.27],0.485568271705958
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.85-1.26],0.746401836753346
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,1.04 [0.88-1.24],0.643894618755812
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FCRLB,Fc receptor-like B,Inverse variance weighted,65,0.99 [0.91-1.07],0.799707093052672
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,0.96 [0.89-1.04],0.351349780015565
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,0.94 [0.87-1.02],0.111929765817488
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.05 [0.96-1.16],0.276574889693069
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GSN,Gelsolin,Inverse variance weighted,7,1.04 [0.63-1.71],0.878276021537545
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,1.04 [0.83-1.30],0.736084439097526
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,0.92 [0.60-1.40],0.692542373031962
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.05 [0.68-1.62],0.809874543819357
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,0.98 [0.83-1.17],0.863773629715827
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,0.79 [0.51-1.23],0.291457148773177
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GLO1,Lactoylglutathione lyase,Inverse variance weighted,11,0.93 [0.78-1.12],0.470355594961822
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.00 [0.91-1.10],0.971322963307242
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,25,1.03 [0.90-1.17],0.707446121987349
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,1.75 [1.04-2.94],0.0340126569843273
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CSTB,Cystatin-B,Inverse variance weighted,25,0.91 [0.81-1.03],0.126390693314848
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HYAL1,Hyaluronidase-1,Inverse variance weighted,23,0.90 [0.78-1.03],0.129445303832621
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AMBP,Protein AMBP,Inverse variance weighted,5,0.99 [0.69-1.42],0.961749067717018
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.11 [0.92-1.33],0.274663294629397
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,13,0.99 [0.78-1.25],0.924245129874912
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.15 [1.00-1.31],0.045230611255904
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.98 [0.81-1.18],0.797937987232419
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,18,1.10 [0.86-1.41],0.440570596350453
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL21,C-C motif chemokine 21,Inverse variance weighted,19,0.95 [0.74-1.22],0.683280767179227
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL18,Interleukin-18,Inverse variance weighted,42,1.06 [0.94-1.20],0.366092422038421
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.00 [0.60-1.67],0.994366866794757
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.05 [0.97-1.12],0.224431108076057
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ITGAV,Integrin alpha-V,Inverse variance weighted,14,1.58 [1.18-2.11],0.0022827941489053
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.98 [0.85-1.13],0.739657389381269
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCN4,CCN family member 4,Inverse variance weighted,40,1.02 [0.92-1.13],0.752994085396993
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.04 [0.76-1.41],0.822907574110457
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCG2,Secretogranin-2,Inverse variance weighted,3,0.66 [0.34-1.26],0.204561285848098
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.36 [0.12-1.08],0.0674978145985206
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.10 [0.93-1.30],0.250090409710474
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,0.98 [0.65-1.46],0.9186413411251
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD160,CD160 antigen,Inverse variance weighted,36,1.03 [0.91-1.17],0.604331187200533
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.15 [0.72-1.84],0.555979407970009
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,0.92 [0.42-2.00],0.83570902799649
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PRG2,Bone marrow proteoglycan,Inverse variance weighted,40,1.11 [0.96-1.27],0.163061357406926
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,1.06 [0.86-1.29],0.604580867955199
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.91 [0.68-1.22],0.527713455944237
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,17,1.04 [0.89-1.22],0.648053553448268
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.11 [0.92-1.34],0.26010919625941
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.89 [0.63-1.24],0.482583879445654
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.79 [0.49-1.28],0.341477626052525
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.81 [0.56-1.17],0.256812155993367
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,21,1.10 [0.96-1.27],0.165383593980104
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.94 [0.68-1.32],0.730362813823914
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.89 [0.75-1.07],0.210101884643341
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.16 [0.88-1.52],0.302392634385409
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,1.17 [0.76-1.80],0.478136312727522
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.07 [0.96-1.19],0.254359619570827
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IFNL1,Interferon lambda-1,Inverse variance weighted,9,1.11 [0.80-1.53],0.532555048251532
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PI3,Elafin,Inverse variance weighted,20,0.81 [0.69-0.96],0.0135205566167488
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,0.92 [0.83-1.01],0.077237830863415
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,0.99 [0.83-1.17],0.874451193978557
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.88-1.10],0.724222996862599
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CPM,Carboxypeptidase M,Inverse variance weighted,23,1.05 [0.83-1.33],0.686837665931099
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.98 [0.91-1.06],0.643689572140884
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.85 [0.59-1.22],0.3709414990444
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.70 [1.01-2.86],0.0447444866714346
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DSC2,Desmocollin-2,Inverse variance weighted,16,0.98 [0.80-1.19],0.834328935129075
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC3B,Tetranectin,Inverse variance weighted,9,1.07 [0.85-1.36],0.557393526480822
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.11 [0.81-1.51],0.52121258554358
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.96 [0.50-1.83],0.900313099391326
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,0.34 [0.08-1.40],0.135108312680662
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.92 [0.76-1.12],0.408393467473035
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RETN,Resistin,Inverse variance weighted,28,1.01 [0.87-1.16],0.941659827712416
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.00 [0.85-1.16],0.961874377966773
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.28 [0.77-2.11],0.33765738784708
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.72 [0.43-1.22],0.226916218213083
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,14,0.85 [0.71-1.02],0.0887997611799979
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FBLN2,Fibulin-2,Inverse variance weighted,17,1.02 [0.88-1.18],0.810358760970597
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TCN2,Transcobalamin-2,Inverse variance weighted,66,1.04 [0.97-1.11],0.306801714332052
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,STC1,Stanniocalcin-1,Inverse variance weighted,11,1.07 [0.82-1.40],0.610626631811925
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.08 [0.90-1.30],0.387761439371914
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.94 [0.46-1.95],0.875436699563127
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.17 [0.91-1.52],0.226411999869982
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.45 [0.83-2.52],0.195166318923664
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CTSV,Cathepsin L2,Inverse variance weighted,34,1.07 [0.91-1.27],0.397628004317248
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,29,0.96 [0.87-1.05],0.351277318329279
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.93 [0.77-1.13],0.481656338299335
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CALCA,Calcitonin,Inverse variance weighted,17,1.14 [0.85-1.53],0.365917877676157
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,6,0.83 [0.59-1.17],0.293033930913999
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PPL,Periplakin,Inverse variance weighted,2,0.95 [0.43-2.08],0.889121168634645
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,1.08 [0.93-1.24],0.304126960142209
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.19 [0.87-1.64],0.282863380549983
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,10,0.98 [0.78-1.22],0.849127128730077
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CDH3,Cadherin-3,Inverse variance weighted,12,0.79 [0.57-1.10],0.169162583528665
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.79-1.17],0.699587756592167
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.41 [0.19-0.86],0.0182862366086261
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,1.05 [0.84-1.31],0.670360369414879
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.00 [0.89-1.12],0.948206554820114
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,0.94 [0.85-1.05],0.252179613428885
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,0.81 [0.57-1.14],0.222530928145901
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VWC2,Brorin,Inverse variance weighted,35,1.00 [0.88-1.13],0.996234269238352
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.85 [0.63-1.15],0.299695379110033
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.89 [0.79-1.00],0.0522524424022047
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPO,Erythropoietin,Inverse variance weighted,14,0.87 [0.43-1.76],0.694897417360967
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.89 [0.70-1.14],0.357813730509888
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL20,C-C motif chemokine 20,Inverse variance weighted,8,0.92 [0.64-1.32],0.639895427917593
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIGLEC1,Sialoadhesin,Inverse variance weighted,31,0.90 [0.78-1.04],0.163376585613678
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.10 [0.78-1.56],0.577081182777516
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,REN,Renin,Inverse variance weighted,12,1.07 [0.89-1.30],0.464016202038462
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.03 [0.60-1.78],0.90296153647873
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,44,0.99 [0.91-1.07],0.769379200432737
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SDC1,Syndecan-1,Inverse variance weighted,14,0.81 [0.59-1.11],0.186868182215561
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RNASE6,Ribonuclease K6,Inverse variance weighted,20,0.82 [0.72-0.94],0.0033744344118831
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.95 [0.88-1.02],0.170170058008427
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.70 [0.30-1.61],0.397796281497965
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.02 [0.93-1.12],0.690144910720421
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.89 [0.61-1.28],0.518529505734972
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.92 [0.81-1.04],0.189540918514765
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,1.21 [0.49-3.04],0.67803932630905
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COLEC12,Collectin-12,Inverse variance weighted,13,1.12 [0.88-1.43],0.366895973975981
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.79 [0.56-1.11],0.174229231459044
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.09 [0.88-1.34],0.418256275589669
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.23 [0.94-1.61],0.124840716368913
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.24 [0.70-2.19],0.467596830792662
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,0.96 [0.76-1.22],0.76463408698764
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,0.85 [0.71-1.01],0.0647726217318566
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.90 [0.71-1.14],0.387930885817612
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.14 [0.51-2.55],0.740748454087955
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.98 [0.75-1.27],0.86169759937497
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,0.97 [0.87-1.07],0.511662368913309
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,0.79 [0.62-1.02],0.0745173428036812
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.12 [0.90-1.39],0.319040970943132
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.06 [0.92-1.22],0.420350145564671
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PTN,Pleiotrophin,Inverse variance weighted,7,1.37 [0.92-2.05],0.120423526883538
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.11 [0.93-1.34],0.248738769997463
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.83 [0.60-1.16],0.285815779104126
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,37,0.97 [0.86-1.10],0.645207713745776
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.03 [0.89-1.19],0.654019348961399
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,0.95 [0.83-1.09],0.45809245237945
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PENK,Proenkephalin-A,Inverse variance weighted,21,1.03 [0.88-1.19],0.737938583766048
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.97 [0.89-1.04],0.369745059535596
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.94 [0.74-1.19],0.602468778576255
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.00 [0.86-1.17],0.983829317613904
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.03 [0.82-1.28],0.822394311392537
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.98 [0.91-1.06],0.656760321121169
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LGALS9,Galectin-9,Inverse variance weighted,39,1.16 [1.03-1.31],0.0143701147631683
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ALCAM,CD166 antigen,Inverse variance weighted,11,1.00 [0.78-1.29],0.971575661463733
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.36 [0.71-2.60],0.354160762792286
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.90 [1.04-3.45],0.0364535583028889
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,3,1.22 [0.53-2.79],0.643289739225667
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RBP7,Retinoid-binding protein 7,Inverse variance weighted,15,1.05 [0.81-1.36],0.721274409259892
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,F9,Coagulation factor IX,Inverse variance weighted,3,1.09 [0.52-2.28],0.821177241101901
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,23,0.90 [0.75-1.07],0.233051937421917
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.61 [0.18-2.05],0.422286628409569
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DLL1,Delta-like protein 1,Inverse variance weighted,13,1.05 [0.81-1.36],0.7041635428185
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,0.89 [0.79-1.01],0.0835848567376155
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.91 [0.84-0.99],0.0286265154776863
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,3.93 [1.66-9.28],0.001816652464972
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,0.85 [0.62-1.17],0.32352283312161
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CTSD,Cathepsin D,Inverse variance weighted,24,1.03 [0.83-1.26],0.814047484883476
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.35 [0.77-2.36],0.298394180493728
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.94 [0.70-1.27],0.699974666674993
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,0.98 [0.85-1.13],0.77626497509922
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,0.97 [0.60-1.55],0.884801048487901
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,20,1.09 [0.92-1.30],0.318162383514956
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,17,0.90 [0.70-1.15],0.38496606626639
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.07 [0.94-1.21],0.323843583813423
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PLXNB2,Plexin-B2,Inverse variance weighted,37,1.00 [0.93-1.07],0.950640209332041
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,0.81 [0.63-1.04],0.0975665491950164
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.06 [0.22-5.18],0.945598359402808
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,19,1.11 [0.91-1.35],0.321943212368525
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PSAP,Prosaposin,Inverse variance weighted,13,1.13 [0.93-1.37],0.221983089443179
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,0.94 [0.86-1.03],0.205398260036966
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.78 [0.49-1.25],0.302777888125637
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,1.01 [0.65-1.58],0.951205134429191
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,0.93 [0.55-1.58],0.790928533914099
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,59,0.95 [0.88-1.04],0.299474536717736
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.25 [0.70-2.23],0.444750369618804
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.89 [0.52-1.52],0.676900022080055
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.07 [0.96-1.18],0.225125302785357
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,0.92 [0.70-1.20],0.538818564688885
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SPON2,Spondin-2,Inverse variance weighted,8,0.71 [0.56-0.88],0.002134420334113
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CST3,Cystatin-C,Inverse variance weighted,13,0.98 [0.82-1.16],0.791155684684314
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LMNB2,Lamin-B2,Inverse variance weighted,9,1.04 [0.68-1.59],0.853988878322591
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.93 [0.75-1.15],0.494544825358387
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.08 [0.90-1.29],0.41224623714594
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.83 [0.16-4.39],0.830191831490807
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EFNA1,Ephrin-A1,Inverse variance weighted,15,0.87 [0.74-1.03],0.114549387083716
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,1.00 [0.90-1.11],0.972714475207131
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,15,0.89 [0.69-1.14],0.34469912576994
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.09 [0.84-1.41],0.522661177474645
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,1.01 [0.87-1.19],0.860160639165743
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL6,Interleukin-6,Inverse variance weighted,6,0.97 [0.75-1.26],0.816790814729631
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,0.97 [0.86-1.10],0.688934511425401
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TMSB10,Thymosin beta-10,Wald ratio,1,0.46 [0.16-1.28],0.13662455852455
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,35,0.98 [0.92-1.04],0.472369003137654
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FOLR1,Folate receptor alpha,Inverse variance weighted,10,0.89 [0.66-1.20],0.439973283696556
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,1.01 [0.75-1.36],0.959897153830167
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,24,0.97 [0.87-1.09],0.616913361353801
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,1.08 [0.87-1.35],0.470965048023206
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACY1,Aminoacylase-1,Inverse variance weighted,11,1.32 [1.02-1.69],0.0320525080678148
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AREG,Amphiregulin,Inverse variance weighted,7,0.98 [0.71-1.36],0.915517631798422
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,0.97 [0.52-1.79],0.916745994746213
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MVK,Mevalonate kinase,Inverse variance weighted,3,0.55 [0.29-1.03],0.0632897135714994
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.90-1.30],0.397965617723177
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,UPB1,Beta-ureidopropionase,Inverse variance weighted,4,1.23 [0.52-2.90],0.639730671307407
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,0.87 [0.69-1.10],0.250306056829405
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EDN1,Endothelin-1,Inverse variance weighted,3,0.98 [0.69-1.39],0.924857018757897
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.92-1.21],0.464050701804614
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.06 [0.89-1.26],0.501049592481655
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,1.02 [0.84-1.23],0.876697491685428
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.12 [0.91-1.38],0.269455995162914
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,0.96 [0.86-1.08],0.539955375227042
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.92-1.13],0.717676411644246
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,1.04 [0.86-1.26],0.676797691991669
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MMP7,Matrilysin,Inverse variance weighted,15,1.24 [1.05-1.46],0.0130597162187252
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.18 [0.98-1.43],0.0821482484491679
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,1.15 [0.70-1.86],0.583627879932367
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,28,0.82 [0.67-1.00],0.0557779276899857
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.05 [0.99-1.12],0.129523194655059
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,0.98 [0.85-1.13],0.797767005768022
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CCL27,C-C motif chemokine 27,Inverse variance weighted,12,1.26 [0.98-1.62],0.0774784594655879
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,0.39 [0.07-2.25],0.289678794682502
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.02 [0.89-1.17],0.732811927248221
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,1.01 [0.81-1.26],0.906025356339343
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CAPG,Macrophage-capping protein,Inverse variance weighted,34,0.94 [0.82-1.07],0.353239127562434
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,0.77 [0.63-0.94],0.0106875107652255
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,1.25 [0.90-1.73],0.176258993139464
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.06 [0.92-1.22],0.442889090912422
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.25 [0.96-1.64],0.103431633078959
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,31,1.02 [0.95-1.08],0.611124250517742
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.22 [0.81-1.84],0.351039282808032
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,0.96 [0.87-1.06],0.381559668662011
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,STC2,Stanniocalcin-2,Inverse variance weighted,12,1.45 [1.05-2.02],0.0261459841046774
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.92 [0.60-1.42],0.72135678743839
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,0.95 [0.81-1.12],0.568088306812521
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL15,Interleukin-15,Inverse variance weighted,35,0.97 [0.82-1.16],0.764200054758917
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.81 [0.63-1.05],0.109878584680554
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,29,1.17 [0.98-1.41],0.0876664710168659
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CDH2,Cadherin-2,Inverse variance weighted,21,1.05 [0.65-1.71],0.837556324560233
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SIAE,Sialate O-acetylesterase,Inverse variance weighted,9,0.93 [0.70-1.23],0.611404864234594
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,27,0.99 [0.91-1.07],0.736675082399295
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.94 [0.82-1.09],0.405424044418492
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.88 [0.68-1.13],0.324949224654087
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD48,CD48 antigen,Inverse variance weighted,32,0.95 [0.86-1.04],0.241599766087576
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.95-1.22],0.22761264359843
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.33 [0.48-3.65],0.580917800047632
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,16,1.02 [0.82-1.27],0.836077781923726
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.13 [0.93-1.38],0.214468552298652
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,0.97 [0.80-1.16],0.706771127040068
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.91 [0.78-1.06],0.221419882250786
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,POF1B,Protein POF1B,Inverse variance weighted,4,1.29 [0.52-3.20],0.582460906664586
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.39 [0.50-3.89],0.525124814154116
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,0.97 [0.85-1.11],0.698226104797152
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,1.02 [0.84-1.24],0.827262373315559
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,EFNA4,Ephrin-A4,Inverse variance weighted,5,1.03 [0.66-1.62],0.892917952568778
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.01 [0.78-1.31],0.920710253352778
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,C7,Complement component C7,Inverse variance weighted,60,1.03 [0.97-1.10],0.303319519056961
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.94 [0.77-1.14],0.520455638011099
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.16 [0.80-1.69],0.42044790600878
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,14,1.04 [0.84-1.29],0.737946334837575
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.85 [0.61-1.18],0.334831272730146
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,1.27 [1.05-1.53],0.013649221458797
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PGA4,Pepsin A-4,Inverse variance weighted,9,0.82 [0.55-1.21],0.316221193951536
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.26 [1.05-1.50],0.0107771822168106
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,0.98 [0.86-1.12],0.794008467162747
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.86 [0.72-1.03],0.0991090087521425
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.91 [0.66-1.26],0.582990710842502
